Literature DB >> 10532680

Common carotid intima-media thickness in patients with peripheral arterial disease or abdominal aortic aneurysm: the SMART study. Second Manifestations of ARTerial disease.

P C Simons1, A Algra, M L Bots, J D Banga, D E Grobbee, Y van der Graaf.   

Abstract

Evidence is emerging that the contribution of atherosclerosis to the development of abdominal aortic aneurysm may differ from that of other manifestations of arterial disease. B-mode ultrasound may be helpful in understanding the characteristics and factors that contribute to the development of different manifestations of arterial disease. We examined whether there is a difference in common carotid intima-media thickness (IMT), an indicator of generalized atherosclerosis, in patients with peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA). IMT of the left and right common carotid artery was measured in the first 172 patients (123 PAD and 49 AAA) enrolled in the Second Manifestations of ARTerial disease (SMART) study, a cohort study among patients with a manifestation of atherosclerotic vascular disease or risk factors for atherosclerosis. Mean IMT was 0.98 +/- 0.34 mm in patients with PAD and 0.91 +/- 0.20 mm in patients with AAA, with an age and sex adjusted mean difference of 0.18 mm (95% CI 0.08; 0.28). After additional adjustments for cardiovascular risk factors, the difference remained 0.11 mm (95% Cl 0.01; 0.21). Common carotid IMT in patients with AAA is on average smaller than in patients with PAD, independent of other determinants of IMT. These findings support the view that the development of AAA cannot completely be explained by atherosclerosis and is in part due to other pathophysiological mechanisms.

Entities:  

Mesh:

Year:  1999        PMID: 10532680     DOI: 10.1016/s0021-9150(99)00142-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Monocytic adhesion molecule expression and monocyte-endothelial cell dysfunction are increased in patients with peripheral vascular disease versus patients with abdominal aortic aneurysms.

Authors:  Eugene S Lee; Elyse N Van Spyk; Kevin C Chun; Robert L Pitts; Mack H Wu; Sarah Y Yuan
Journal:  J Surg Res       Date:  2012-07-07       Impact factor: 2.192

2.  Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II.

Authors:  Jun-o Deguchi; Hayden Huang; Peter Libby; Elena Aikawa; Peter Whittaker; Jeremy Sylvan; Richard T Lee; Masanori Aikawa
Journal:  Lab Invest       Date:  2009-01-19       Impact factor: 5.662

3.  Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population.

Authors:  Alberto Palazzuoli; Palazzuoli Alberto; Maddalena Gallotta; Gallotta Maddalena; Giuseppe Guerrieri; Guerrieri Giuseppe; Ilaria Quatrini; Quatrini Ilaria; Beatrice Franci; Maria Stella Campagna; Eugenio Neri; Neri Eugenio; Antonio Benvenuti; Benvenuti Antonio; Carlo Sassi; Sassi Carlo; Ranuccio Nuti; Nuti Ranuccio
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.